药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
alpha-methylthiofentanyl
Iloperidone
The risk or severity of QTc prolongation can be increased when Talinolol is combined with Iloperidone.
alpha-methylthiofentanyl
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Talinolol is combined with Tetrabenazine.
alpha-methylthiofentanyl
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Talinolol is combined with Zuclopenthixol.
alpha-methylthiofentanyl
Poractant alfa
Poractant alfa may increase the bradycardic activities of Talinolol.
alpha-methylthiofentanyl
Tofacitinib
Tofacitinib may increase the bradycardic activities of Talinolol.
alpha-methylthiofentanyl
Lanreotide
Lanreotide may increase the bradycardic activities of Talinolol.
alpha-methylthiofentanyl
Beractant
Beractant may increase the bradycardic activities of Talinolol.
alpha-methylthiofentanyl
Calfactant
Calfactant may increase the bradycardic activities of Talinolol.
alpha-methylthiofentanyl
Lacosamide
Lacosamide may increase the bradycardic activities of Talinolol.
alpha-methylthiofentanyl
Lucinactant
Lucinactant may increase the bradycardic activities of Talinolol.
alpha-methylthiofentanyl
Encorafenib
The risk or severity of QTc prolongation can be increased when Encorafenib is combined with Talinolol.
alpha-methylthiofentanyl
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Talinolol is combined with Dexchlorpheniramine.
alpha-methylthiofentanyl
Sultopride
The risk or severity of QTc prolongation can be increased when Talinolol is combined with Sultopride.
alpha-methylthiofentanyl
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Talinolol is combined with Sitafloxacin.
alpha-methylthiofentanyl
Oxatomide
The risk or severity of QTc prolongation can be increased when Talinolol is combined with Oxatomide.
alpha-methylthiofentanyl
Abexinostat
The risk or severity of QTc prolongation can be increased when Talinolol is combined with Abexinostat.
alpha-methylthiofentanyl
Mizolastine
The risk or severity of QTc prolongation can be increased when Talinolol is combined with Mizolastine.
alpha-methylthiofentanyl
Ricolinostat
The risk or severity of QTc prolongation can be increased when Talinolol is combined with Ricolinostat.
alpha-methylthiofentanyl
CUDC-101
The risk or severity of QTc prolongation can be increased when Talinolol is combined with CUDC-101.
alpha-methylthiofentanyl
Gilteritinib
The risk or severity of QTc prolongation can be increased when Talinolol is combined with Gilteritinib.